(BFM Stock Exchange) – The Parisian star index continues a third session in the red, feverish before the outcome of the monetary policy of the American Federal Reserve (Fed), and still awaiting new developments on the customs duties.

Never two without three. The Paris Stock Exchange continues a third session in the red, with a CAC 40 which gave 0.91% to 7,626,84 points, at the end of this session of Wednesday May 7.

The market shows caution before the end of the monetary policy meeting of the American Federal Reserve (Fed). The central bank will make its decision to public at 8 p.m. No change on rates is expected by the market.

“We believe that the Fed will be patient” on the rate reductions, “but that it will act decisively if the labor market shows clear signs of deterioration,” said Pictet AM. “Consequently, the key question of the calendar of a drop in rates is whether and when the concrete data will indicate a sufficient economic slowdown for the Fed to intervene,” she concludes.

Sanofi Red Lantern of CAC 40

The Parisian market has hardly taken advantage of a small clarity on the front of the commercial showdown between China and the United States.

“The two parties announced discussions in Switzerland on Saturday and Sunday, under the direction of the secretary of the Treasury Bessent and the GREER trade representative for the United States, and the Vice-Prime Minister Lifeng for China,” said Deutsche Bank. “These would be the first substantive discussions between the two largest economies in the world since the introduction, a month ago, of 125%prohibitive customs surcharge,” added the German bank.

Recall that the Paris market will be open Thursday, May 8, a holiday but not unemployed on the Paris Stock Exchange, which risks weighing heavily on volumes.

On the values ​​side, Legrand resumed 3% after giving greater growth in the expectations in the first quarter.

Red lantern of the CAC 40, Sanofi closing in net with 4.3%, penalized like other pharmaceutical groups by the appointment of Vinay Prasad, an oncologist deemed hostile to industry, at a key position of the Food and Drug Administration (FDA), the American health authority.

Excluding CAC 40, JCDecaux was sanctioned (-6.6%) for delivering prospects for the second quarter below expectations.

Scor took the lead in the SBF 120 after quarterly results deemed reassuring by the market, followed by Trigano which won 3.6% supported on its side by UBS which initiated its coverage to purchase.

In other markets, the euro is stable against the dollar at $ 1.1348. Black gold prices fall back down in response to a more pronounced withdrawal than expected from American petroleum stocks. The July Brent of the Northern Brents contract dropped 1.1% to 61.46 Dollars per barrel while that of July on the WTI listed in New York cedes 1% to 58.47 Dollars per barrel.